A Randomized, Double-blind, Multicenter Trial Comparing Efficacy and Safety of Imipenem/Cilastatin/Relebactam Versus Piperacillin/Tazobactam in Adults With Hospital-acquired or Ventilator-associated Bacterial Pneumonia (RESTORE-IMI 2 Study)Ivan Titov, Luke F. Chen, Amanda Paschke et al.|Clinical Infectious Diseases|2020Cited by 232
Virologic Outcomes with Molnupiravir in Non-hospitalized Adult Patients with COVID-19 from the Randomized, Placebo-Controlled MOVe-OUT TrialJulie Strizki, Carisa De Anda, Patricia Carmelitano et al.|Infectious Diseases and Therapy|2023Cited by 11
Correction to: Virologic Outcomes with Molnupiravir in Nonhospitalized Adult Patients with COVID-19 from the Randomized, Placebo-Controlled MOVe-OUT TrialJulie Strizki, Carisa De Anda, Jay A. Grobler et al.|Infectious Diseases and Therapy|2024Cited by 1